Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
HYPR Stock Forecast 2026-2027
$1.33
Current Price
$128.57M
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to HYPR Price Targets
+88.0%
To High Target of $2.50
+54.1%
To Median Target of $2.05
+20.3%
To Low Target of $1.60
HYPR Price Momentum
+9.9%
1 Week Change
+4.7%
1 Month Change
+90.0%
1 Year Change
+35.7%
Year-to-Date Change
-40.1%
From 52W High of $2.22
+149.5%
From 52W Low of $0.53
📊 TOP ANALYST CALLS
Did HYPR Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Hyperfine is one of their latest high-conviction picks.
Latest HYPR Stock Price Targets & Analyst Predictions
Based on our analysis of 6 Wall Street analysts, HYPR has a bullish consensus with a median price target of $2.05 (ranging from $1.60 to $2.50). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $1.33, the median forecast implies a 54.1% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Frank Takkinen at Lake Street, projecting a 88.0% upside. Conversely, the most conservative target is provided by Larry Biegelsen at Wells Fargo, suggesting a 20.3% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
HYPR Analyst Ratings
2
Buy
0
Hold
0
Sell
HYPR Price Target Range
Low
$1.60
Average
$2.05
High
$2.50
Current: $1.33
Latest HYPR Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for HYPR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 19, 2026 | Lake Street | Frank Takkinen | Buy | Maintains | $2.50 |
| Aug 15, 2025 | Wells Fargo | Larry Biegelsen | Equal-Weight | Maintains | $0.85 |
| Aug 14, 2025 | Lake Street | Frank Takkinen | Buy | Maintains | $2.00 |
| May 15, 2025 | B. Riley Securities | Yuan Zhi | Buy | Maintains | $1.00 |
| May 14, 2025 | Wells Fargo | Larry Biegelsen | Equal-Weight | Maintains | $0.68 |
| Mar 24, 2025 | Lake Street | Frank Takkinen | Buy | Initiates | $1.50 |
| Mar 20, 2025 | B. Riley Securities | Yuan Zhi | Buy | Maintains | $1.20 |
| Mar 18, 2025 | Wells Fargo | Larry Biegelsen | Equal-Weight | Maintains | $1.29 |
| Mar 22, 2024 | Wells Fargo | Larry Biegelsen | Equal-Weight | Maintains | $1.60 |
| Nov 30, 2023 | Jefferies | Young Li | Hold | Initiates | $1.25 |
| Aug 15, 2023 | B. Riley Securities | Neil Chatterji | Buy | Maintains | $3.50 |
| Mar 22, 2023 | B. Riley Securities | Neil Chatterji | Buy | Maintains | $2.50 |
| Oct 4, 2022 | B. Riley Securities | Neil Chatterji | Buy | Initiates | $3.50 |
| Aug 11, 2022 | Wells Fargo | Larry Biegelsen | Equal-Weight | Downgrade | $2.40 |
| May 31, 2022 | Evercore ISI Group | Outperform | Initiates | $N/A | |
| Apr 14, 2022 | Wells Fargo | Overweight | Initiates | $N/A |
Hyperfine Inc. (HYPR) Competitors
The following stocks are similar to Hyperfine based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Hyperfine Inc. (HYPR) Financial Data
Valuation Metrics
Market Cap
$128.57M
Enterprise Value
$87.68M
P/E Ratio
N/A
PEG Ratio
-3.9x
Price/Sales
9.4x
Growth & Margins
Revenue Growth (YoY)
+128.0%
Gross Margin
+50.9%
Operating Margin
-144.9%
Net Margin
-262.3%
EPS Growth
+128.0%
Financial Health
Cash/Price Ratio
+26.9%
Current Ratio
4.3x
Debt/Equity
0.8x
ROE
-79.0%
ROA
-40.6%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Hyperfine Inc. (HYPR) Business Model
About Hyperfine Inc.
What They Do
Develops portable, low-cost MRI systems.
Business Model
Hyperfine Inc. generates revenue through the sale of its innovative Swoop Portable MRI systems, which are designed for use in various healthcare environments, including emergency rooms and remote locations. By offering a more accessible and affordable alternative to traditional MRI machines, the company targets healthcare providers looking to enhance patient care and streamline diagnosis.
Additional Information
The company's focus on making advanced imaging technology available in diverse settings can significantly impact hospital operations and patient management. With the potential to democratize healthcare access, Hyperfine Inc. is positioned as a transformative player in the medical technology industry.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
102
CEO
Ms. Maria Degois-Sainz
Country
United States
IPO Year
2021
Website
www.hyperfinemri.comHyperfine Inc. (HYPR) Latest News & Analysis
Latest News
Quick Summary
Hyperfine's Swoop system and Optive AI software have received CE and UKCA marks, enabling the launch of their advanced portable MRI technology in European markets.
Why It Matters
Hyperfine's CE & UKCA marks for its advanced MRI tech enable market expansion in Europe, potentially increasing revenue and market share, positively impacting investor sentiment.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Horizon Technology Finance Corporation has provided a $40 million loan facility to Hyperfine, Inc., with an initial $15 million disbursed and $25 million available for future growth.
Why It Matters
Horizon Technology's $40 million loan to Hyperfine signals confidence in Hyperfine's growth potential, potentially boosting investor sentiment and stock performance for both companies.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Hyperfine, Inc. (HYPR) conducted its Q4 2025 earnings call, providing insights into financial performance and strategic developments. No specific financial figures or details were included.
Why It Matters
Hyperfine, Inc.'s Q4 2025 earnings call reveals financial performance and strategic direction, impacting stock valuation, investor sentiment, and future growth potential.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Hyperfine, Inc. (Nasdaq: HYPR) announced its 2025 Q4 and full-year financial results, highlighting the launch of its second-gen Swoop® scanner and Optive AI™ software for neurology offices.
Why It Matters
Hyperfine's launch of new products and expansion into neurology can drive revenue growth and market share, impacting stock performance and investor sentiment positively.
Source: Business Wire
Market Sentiment:
Neutral
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
1 month ago
Quick Summary
Hyperfine, Inc. (Nasdaq: HYPR) will report Q4 and full-year 2025 financial results on March 18, 2026, with a conference call scheduled for 1:30 PM PT / 4:30 PM ET.
Why It Matters
Hyperfine's upcoming financial results announcement and conference call could impact its stock price and investor sentiment, reflecting the company's market performance and growth potential in innovative health technology.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
AI-powered portable MRI shows strong potential for stroke detection across various clinical settings, including emergency departments, according to recent evidence.
Why It Matters
Advancements in AI-powered MRI technology for stroke detection could improve patient outcomes, reduce costs, and enhance operational efficiency, impacting healthcare investments and market dynamics.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About HYPR Stock
What is Hyperfine Inc.'s (HYPR) stock forecast for 2026?
Based on our analysis of 6 Wall Street analysts, Hyperfine Inc. (HYPR) has a median price target of $2.05. The highest price target is $2.50 and the lowest is $1.60.
Is HYPR stock a good investment in 2026?
According to current analyst ratings, HYPR has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.33. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for HYPR stock?
Wall Street analysts predict HYPR stock could reach $2.05 in the next 12 months. This represents a 54.1% increase from the current price of $1.33. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Hyperfine Inc.'s business model?
Hyperfine Inc. generates revenue through the sale of its innovative Swoop Portable MRI systems, which are designed for use in various healthcare environments, including emergency rooms and remote locations. By offering a more accessible and affordable alternative to traditional MRI machines, the company targets healthcare providers looking to enhance patient care and streamline diagnosis.
What is the highest forecasted price for HYPR Hyperfine Inc.?
The highest price target for HYPR is $2.50 from Frank Takkinen at Lake Street, which represents a 88.0% increase from the current price of $1.33.
What is the lowest forecasted price for HYPR Hyperfine Inc.?
The lowest price target for HYPR is $1.60 from Larry Biegelsen at Wells Fargo, which represents a 20.3% increase from the current price of $1.33.
What is the overall HYPR consensus from analysts for Hyperfine Inc.?
The overall analyst consensus for HYPR is bullish. Out of 6 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $2.05.
How accurate are HYPR stock price projections?
Stock price projections, including those for Hyperfine Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 17, 2026 8:49 PM UTC